IP Library › Granted Patent US 10,815,456
Granted Patent B2
US 10,815,456 · App. 15/723,934 · Granted Oct 27, 2020

Composition, kit and method for cryopreserving cells

Inventors: Bin-Ru She (Hsinchu, TW); Kun-Chi Chiang (Hsinchu, TW); Cheng-Yi Lin (Hsinchu, TW); Ting-Yu Huang (Hsinchu, TW)
Assignee: TRANSWELL BIOTECH CO., LTD.
C12N5/0018A01N1/0221C12N5/0068C12N5/0607C12N5/0656C12N5/0693C12N2533/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,815,456
App. No.
15/723,934
Granted
Oct 27, 2020
Kind
B2
Abstract

The present disclosure provides for a cryopreservation composition comprising a permeating cryoprotectant, a saccharide and a macromolecule. The cryopreservation composition has a low toxicity to cells and tissues, and promotes survival and retention of viability of the biological material during cryopreservation.

Claims (34)

1. A cryopreservation composition comprising:

(1) about 2% (w/v) to about 20% (w/v) of polyethylene glycol;

(2) about 0.1 M to about 0.5 M of a saccharide; and

(3) about 1% (w/v) to about 10% (w/v) of gelatin,

wherein the unit of % (w/v) and the unit of M are based on the total volume of the cryopreservation composition.

2. The cryopreservation composition of claim 1 , wherein the saccharide comprises sucrose, trehalose, or a combination thereof.

3. The cryopreservation composition of claim 1 , wherein the gelatin has a molecular weight ranging from about 50 kDa to about 200 kDa.

4. The cryopreservation composition of claim 1 , substantially free of DMSO.

5. The cryopreservation composition of claim 1 , further comprising an amino acid, a cytokine, a lipid, a growth factor, an antibiotic, an antimycotic, a steroid hormone, a protein hormone, or a combination thereof.

6. The cryopreservation composition of claim 1 , further comprising one or more cells.

7. The cryopreservation composition of claim 6 , in a cryopreserved state.

8. The cryopreservation composition of claim 6 , wherein the cells are present at a concentration ranging from about 10 5 cells/ml to about 10 7 cells/ml.

9. The cryopreservation composition of claim 1 , comprising:

about 1% (w/v) to about 5% (w/v) of gelatin.

10. The cryopreservation composition of claim 9 , further comprising one or more cells.

11. The cryopreservation composition of claim 10 , in a cryopreserved state.

12. The cryopreservation composition of claim 9 , wherein the cells are present at a concentration ranging from about 10 5 cells/ml to about 10 7 cells/ml.

13. The cryopreservation composition of claim 1 , wherein the saccharide comprises sucrose, sorbitol, glucose, fructose, galactose, trehalose, mannose, maltose, or combinations thereof.

14. The cryopreservation composition of claim 9 , wherein the saccharide comprises sucrose, sorbitol, glucose, fructose, galactose, trehalose, mannose, maltose, or combinations thereof.

15. A kit comprising the cryopreservation composition of claim 1 .

16. A method for cryopreserving one or more cells, the method comprising the steps of:

(a) mixing the one or more cells with the cryopreservation composition of claim 1 to form a mixture, and

(b) freezing the mixture.

17. The method of claim 16 , wherein the cells are mammalian cells.

18. The method of claim 16 , wherein the cells are human, porcine, canine, equine or bovine cells.

19. The method of claim 16 , wherein the cells comprise tumor cells.

20. The method of claim 16 , wherein the cells comprise fibroblasts.

21. The method of claim 16 , wherein the cells comprise stem cells.

22. The method of claim 16 , wherein the mixture is frozen at a temperature ranging from about −70° C. to about −200° C.

23. The method of claim 16 , wherein the cells are present in the mixture at a concentration ranging from about 10 5 cells/ml to about 10 7 cells/ml.

24. The method of claim 16 , wherein the cryopreservation composition is substantially free of DMSO.

25. The method of claim 16 , further comprising the step (c) thawing the frozen mixture.

26. The method of claim 25 , wherein the cells have a post-thaw viability of at least 70%.

27. The method of claim 25 , wherein the cells have a post-thaw viability of at least 80%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2019
From: SHE, BIN-RU; CHIANG, KUN-CHI; LIN, CHENG-YI; HUANG, TING-YU
To: TRANSWELL BIOTECH CO., LTD.
Reel/Frame 049460/0826 →
Continuity (3)
Provisional Application 62405447 · Oct 7, 2016
Provisional Application 62404170 · Oct 4, 2016
Related Publication 20180092348A1 · Apr 5, 2018
Cited By (2)
US 12,426,594 US 12,453,805